Mainz Biomed B.V.   (NASDAQ:MYNZ)

12.25    $0.74   6.47%
Market open   Sunday, May 22 2022 12:41 PM

Mainz Biomed B.V. Chart

MYNZ Stock Price Today

Mainz Biomed B.V. (MYNZ) stock rallied over 6.47% intraday to trade at $12.25 a share on NASDAQ. The stock opened with a gain of 3.04% at $11.86 and touched an intraday high of $12.25, rising 6.43% against the last close of $11.51. The stock went to a low of $11.50 during the session.

Stock Snapshot

11.51
Prev. Close
11.86
Open
143.45M
Market Cap
11.71M
Number of Shares
11.50
day Low
12.25
Day High
12.25
-
P/E ratio
-%
Free Float in %
-1.62
EPS (TTM)
0.11
Book Value per Share
-
Cash Flow per Share
27651
Volume

Mainz Biomed B.V. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$11.86$12.25$12.25$11.5027,700
2022-05-19$11.65$11.51$11.67$11.288,100
2022-05-18$11.51$11.10$11.65$11.026,300
2022-05-17$11.10$11.91$12.18$11.1020,000
2022-05-16$10.94$11.21$11.50$10.7518,400
2022-05-13$10.88$11.23$11.35$10.7723,300
2022-05-12$11.00$10.75$11.25$9.5857,600
2022-05-11$11.14$11.00$11.56$11.0036,100
2022-05-10$11.70$11.33$11.70$10.9138,100
2022-05-09$11.93$11.00$12.20$11.0059,400
2022-05-06$14.23$12.20$14.23$12.00121,300

Contact Details

Robert Koch Strasse 50
Mainz 55129
Germany
https://mainzbiomed.com
49 6131 554 2860

About Company

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Frequently Asked Questions

What is the current Mainz Biomed B.V. (MYNZ) stock price?

Mainz Biomed B.V. (NASDAQ: MYNZ) stock price is $12.25 as of the last check on Sunday, May 22 2022. During the trading session, MYNZ stock reached the peak price of $12.25 while $11.50 was the lowest point it dropped to.

MYNZ's industry and sector of operation?

The NASDAQ listed MYNZ is part of Diagnostics & Research industry that operates in the broader Healthcare sector. Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics.

Who are the executives of MYNZ?

Mr. Guido Baechler
CEO & Director

Mr. William J. Caragol
Chief Financial Officer

Mr. Philipp Freese
Chief Operating Officer

Dr. Moritz Eidens Ph.D.
Chief Science Officer & Director


What is the MYNZ stock price today?

MYNZ stock is trading at $12.25 today, which is $0.74 or 6.47% higher than its previous close of $11.51. MYNZ's current trading price is -59.17% lower than its 52-week high of $30.00 where as its distance from 52-week low of $7.80 is 57.05%.

Link for MYNZ official website?


How do I contact MYNZ?

MYNZ could be contacted at Robert Koch Strasse 50
Mainz 55129
Germany, or at phone # 49 6131 554 2860 and can also be accessed through its website: https://mainzbiomed.com

How many shares of MYNZ are traded daily?

MYNZ stock volume so far today is 27651 shares while in the previous session number of MYNZ shares traded was 27700. The average number of MYNZ shares traded daily for last 3 months was 46510.

How much did MYNZ change today?

The percentage change in MYNZ stock occurred in the recent session was 6.47% while the dollar amount for the price change in MYNZ stock was $0.74.

What price range MYNZ stock been trading in?

In the recent session, the day high for MYNZ stock was $12.25 while the low for MYNZ stock touched on the day was $11.50.

What is the market cap of MYNZ currently?

The market value of MYNZ currently stands at $143.45M with its latest stock price at $12.25 and 11.71M of its shares outstanding.